Evidence map›Paper›PMID 38330189›Full record

ArticleJournal of global health2024

COVID-19 monitoring of school personnel through molecular salivary test and dried blood spot analysis.

Dolaji Henin, Clara Fappani, Daniela Carmagnola, Maria Gori, Gaia Pellegrini, Daniela Colzani, Antonella Amendola, Mariachiara Perrotta, Elisabetta Tanzi, Claudia Dellavia

Open access · goldAbstract read
In one paragraph

Article in Journal of global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Dolaji Henin *Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Milan, Italy.
Clara Fappani *Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Daniela CarmagnolaDepartment of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Milan, Italy.
Maria GoriDepartment of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Gaia PellegriniDepartment of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Milan, Italy.
Daniela ColzaniDepartment of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Antonella AmendolaDepartment of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Mariachiara PerrottaDepartment of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Milan, Italy.
Elisabetta TanziDepartment of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Claudia DellaviaDepartment of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Milan, Italy.
University of Milan · ITCentre for Multidisciplinary Research in Health Science · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: When the coronavirus disease 2019 (COVID-19) pandemic broke out, most countries enforced school closures as a precautionary measure. Although COVID-19 is still present three years later, schools have been reopened. We aimed to test the association of molecular salivary testing (MST) and dried blood spot (DBS) analysis for community surveillance by investigating the immunological profile of a group of school staff during and following COVID-19 vaccination. Methods: We conducted the study in a school in Milan from April 2021, when school staff were administered the first dose of vaccine against SARS-CoV-2, until the school year ended in June 2022. Each participant provided samples for MST and DBS one month (T1, W1) after receiving their first dose of vaccine. Subsequently, they collected weekly MST samples for five weeks (W2-W6), plus a DBS sample in the last week (T2). Both samples were collected one (T3), four (T4), and seven months (T5) after the administration of the second vaccine dose in May 2021. A final DBS sample was collected one year (T6) after T3. Results: Sixty participants provided 327 MSTs and 251 DBSs. None of the MST samples tested positive for SARS-CoV-2 RNA during the study period. A total of 201 DBS samples tested positive for the IgG semiquantitative analysis. Negative samples were found only at T1 (20.45%) and T2 (7.32%). We observed borderline results at T1 (4.55%), T2 (7.32%), and T4 (2.70%). The anti-SARS-CoV-2 average antibody ratio increased after the second dose between T2 and T3, and the trend peaked after the third dose between T4 and T6. We performed an immunoenzymatic assay of antibodies against nucleocapsid protein on samples collected at T1 from five participants who reported having been infected before the study and from four subjects with an abnormal increase in the antibody values at T4. Two samples tested positive in the first group and two in the second one. Conclusions: Our findings show that MST and DBS could be effective tools in the active surveillance of school personnel and that schools could be considered safe settings in view of SARS-CoV-2 infection. Vaccines might have contributed to case and/or symptom reduction.

Indexed as

COVID-19COVID-19 VaccinesAntibodies, ViralDried Blood Spot TestingHumansRNA, ViralSARS-CoV-2SchoolsAntibodies, ViralCOVID-19 VaccinesRNA, Viral

Identifiers

PMID38330189
PMCPMC10852534
OpenAlexW4391638578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.